The Current Ratio as of November 2024 (TTM) for BioRestorative Therapies, Inc. (BRTX) is 2.82

According to BioRestorative Therapies, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.82. This represents a change of -55.88% compared to the average of 6.39 of the last 4 quarters.

BioRestorative Therapies, Inc. (BRTX) Historical Current Ratio (quarterly & annually)

How has BRTX Current Ratio performed in the past?

The mean historical Current Ratio of BioRestorative Therapies, Inc. over the last ten years is 10.09. The current 2.82 Current Ratio has changed 2.69% with respect to the historical average. Over the past ten years (40 quarters), BRTX's Current Ratio was at its highest in in the December 2021 quarter at 59.01. The Current Ratio was at its lowest in in the March 2020 quarter at 0.00.

BioRestorative Therapies, Inc. (BRTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioRestorative Therapies, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioRestorative Therapies, Inc. (BRTX) Average Current Ratio

How has BRTX Current Ratio performed in the past?

The current Current Ratio of BioRestorative Therapies, Inc. (BRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioRestorative Therapies, Inc. (BRTX) Current Ratio vs. Peers

How is BRTX’s Current Ratio compared to its peers?

BioRestorative Therapies, Inc.’s Current Ratio is less than Pulmatrix, Inc. (6.33), greater than Capricor Therapeutics, Inc. (1.37), greater than Akari Therapeutics, Plc (0.58), less than Diffusion Pharmaceuticals Inc. (10.96), less than Soleno Therapeutics, Inc. (29.24), greater than Propanc Biopharma, Inc. (0.03), less than Cadrenal Therapeutics, Inc. Common Stock (3.60), greater than Bonus BioGroup Ltd. (1.95), less than InVivo Therapeutics Holdings Corp. (14.30), greater than Cingulate Inc. (1.20), less than SAB Biotherapeutics, Inc. (5.24), less than Anebulo Pharmaceuticals, Inc. (13.46), less than Monopar Therapeutics Inc. (6.59), less than Can-Fite BioPharma Ltd. (2.93), greater than Candel Therapeutics, Inc. (1.62), less than XTL Biopharmaceuticals Ltd. (11.43), greater than Cingulate Inc. (1.20), less than Achieve Life Sciences, Inc. (4.56), greater than Bio-Path Holdings, Inc. (1.67), less than Icosavax, Inc. (18.06),

Build a custom stock screener for BioRestorative Therapies, Inc. (BRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioRestorative Therapies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioRestorative Therapies, Inc. (BRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioRestorative Therapies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.